SKU(재고 관리 코드):MAC472Hu22
Monoclonal Antibody to Fibulin 1 (FBLN1)
Monoclonal Antibody to Fibulin 1 (FBLN1)
Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.
Product No.
MAC472Hu22
Organism Species
Homo sapiens (Human).
Source
Monoclonal antibody preparation
Host
Mouse
Potency (Clone Number)
D1
Ig Isotype
IgG2b Kappa
Purification
Protein A + Protein G affinity chromatography
Label
None
Immunogen
RPC472Hu01-Recombinant Fibulin 1 (FBLN1)
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
1mg/ml
Organism Species More
Rattus norvegicus (Rat)
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a mouse monoclonal antibody raised against FBLN1. It has been selected for its ability to recognize FBLN1 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Magazine |
Citations |
Clin Exp Metastasis. |
Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression Pubmed:24807734 |
Proteomics Clinical Applications |
Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients Pubmed:26680509 |
PROTEOMICS - Clinical Applications |
Comparative mass spectrometric and immunoassay-based proteome analysis in serum ofDuchenne muscular dystrophy patients. pubmed:26680509 |
ENVIRONMENTAL RESEARCH |
Exploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS Pubmed: 33197421 |
Catalog No. |
Related products for research use of Homo sapiens (Human) Organism species |
Applications (RESEARCH USE ONLY!) |
RPC472Hu02 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
RPC472Hu03 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
RPC472Hu01 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
PAC472Hu02 |
WB; IHC; ICC; IP. |
|
PAC472Hu01 |
WB; IHC; ICC; IP. |
|
LAC472Hu71 |
WB; IHC; ICC. |
|
MAC472Hu21 |
WB; IHC; ICC; IP. |
|
MAC472Hu22 |
WB; IHC; ICC; IP. |
|
LAC472Hu72 |
WB; IHC; ICC. |
|
SEC472Hu |
Enzyme-linked immunosorbent assay for Antigen Detection. |
|
SCC472Hu |
Chemiluminescent immunoassay for Antigen Detection. |
|
LMC472Hu |
Magnetic Luminex Assay for Antigen Detection. |
|
PSC472Hu01 |
ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
|
KSC472Hu01 |
Main materials for "Do It (ELISA Kit) Yourself". |